Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)

Paramount Global Revenue

Jiangsu CoWin Biotech had revenue of 43.01M CNY in the quarter ending March 31, 2025, with 49.31% growth. This brings the company's revenue in the last twelve months to 140.08M, up 13.70% year-over-year. In the year 2024, Jiangsu CoWin Biotech had annual revenue of 125.88M, down -26.54%.

• Revenue (ttm): 140.08M
• Revenue Growth: +13.70%
• P/S Ratio: 18.95
• Revenue / Employee: 168.16K
• Employees: 833
• Market Cap: 2.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	125.88M	-45.47M	-26.54%
Dec 31, 2023	171.34M	-350.26M	-67.15%
Dec 31, 2022	521.60M	183.14M	54.11%
Dec 31, 2021	338.46M	105.25M	45.13%
Dec 31, 2020	233.21M	159.27M	215.41%